Trulicity Approval History
Trulicity (dulaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes.
Development History and FDA Approval Process for Trulicity
|Sep 18, 2014||FDA Approves Trulicity (dulaglutide) for Type 2 Diabetes|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.